Brian J. Druker, M.D.
- Special Interest:
- Chronic Myeloid Leukemia
- Accepting Patients:
"There is no question that we can defeat cancer. What it requires is knowledge. When we understand what is broken, we can fix it."
Dr. Druker specializes in caring for and treating patients with chronic myelogenous leukemia (CML). In his early medical training, witnessing chemotherapy's effects on patients drove him to find a better way to treat cancer. Starting in the lab, he led the development and clinical trials of the drug Gleevec for CML. Gleevec was the first of its kind, highly successful daily oral medication to target damaged cells, leave healthy cells alone and cause minimal side effects. Dr. Druker continues to seek even better treatments for his patients, who are his inspiration.Dr. Druker's favorite way to spend his free time is with his wife, son and two daughters. With his busy schedule, he runs to and from work, rain or shine, to ensure he stays healthy.In 2009, Dr. Druker was honored with "America's Nobel Prize", the Lasker-DeBakey Award for Clinical Medical Research.
M.D., University of California San Diego, 1981
Barnes Hospital, Washington University, St. Louis
Medical Oncology - Dana-Farber Cancer Institute, Harvard Medical School, Boston
American Board of Internal Medicine, 1984 American Board of Internal Medicine, 1987